跳至主要内容
临床试验/EUCTR2020-000548-71-NL
EUCTR2020-000548-71-NL进行中(未招募)1 期

iraglutide for low-responders after bariatric surgery - LIBAR

ederlandse Obesitas Kliniek0 个研究点目标入组 100 人开始时间: 2020年12月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patient is =18 and <75 years old
  • BMI before surgery was = 35 kg/m2
  • Patient is treated with group consultation at the NOK
  • Patient has undergone a primary Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG)
  • Patient is in the lowest %TWL quartile, 3 months after surgery and will be enrolled in the plus module.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Type 1 or type 2 diabetes
  • Decreased renal function (creatinine clearance < 30 ml/min)
  • Liver failure (all)
  • Congestive heart failure or angina pectoris NYHA class III and IV
  • Malignancy in history
  • Pancreatitis (in history)
  • Pregnancy / breast-feeding
  • Inflammatory Bowel Disease
  • Thyroid malignancy in history
  • Use of warfarin or other coumarin derivates

研究者

发起方
ederlandse Obesitas Kliniek

相似试验